The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.

Capricor Therapeutics, Inc. (NASDAQ:CAPR) is one of the most shorted mid-cap and small-cap stocks to buy now. On May 13, B Riley reiterated a Buy rating on Capricor Therapeutics (NASDAQ:CAPR) with a $63 price target. The positive stance comes as the company enters into a pivotal stage in the potential approval of Deramiocel for the treatment of Duchenne muscular dystrophy.

The company is staring at a potential FDA review of a Biologics License Application (BLA) and a PDUFA target set for August. The agency has already accepted the company’s Class 2 resubmission as complete. Capricor’s GMP manufacturing facility in San Diego has also completed an FDA Pre-License Inspection, with all Form 483 observations addressed. The facility is to support the initial commercial launch.

Manufacturing expansion is expected in the first half of 2027, up from the previous late 2027 timeline. Capricor also remains in a solid financial position to cover anticipated expenses and capital requirements through Q4 2027, excluding any potential revenue from product sales.

Capricor Therapeutics, Inc. (NASDAQ:CAPR) is a clinical-stage biotechnology company focused on developing cell and exosome-based therapeutics for rare and serious diseases. Their primary focus is treating Duchenne muscular dystrophy (DMD) through regenerative and anti-inflammatory medicine.

While we acknowledge the potential of CAPR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: Top 10 Small Cap Stocks With Huge Growth Potential and Renaissance Technologies Returns, AUM, CEO and Top 10 Semiconductor Stock Picks.

Disclosure: None. Follow Insider Monkey on Google News.